{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T11:28:30Z","timestamp":1787830110748,"version":"build-2784847793"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"published-print":{"date-parts":[[2008,4]]},"abstract":"<jats:p>Este trabalho identificou variedades de Cryptococcus neoformans e avaliou a suscetibilidade a antif\u00fangicos pelo protocolo M27-A2 do National Committee for Clinical Laboratory Standards em isolados de 35 pacientes do Hospital Escola da Universidade Federal do Tri\u00e2ngulo Mineiro. A variedade gatti foi identificada em 11.4% (n\u00ba = 4) dos casos. A concentra\u00e7\u00e3o inibit\u00f3ria m\u00ednima (mg\/ml) dos isolados de Cryptococcus neoformans neoformans variou de 0,062 - 2,000 (anfotericina B), 0,250 - 8,000 (fluconazol), 0,062 - 1,000 (itraconazol) e 0,125 - 1,000 (cetoconazol). A variedade gattii apresentou concentra\u00e7\u00e3o inibit\u00f3ria m\u00ednima de 0,125 - 2,000 (anfotericina B), 0,250 - 16,00 (fluconazol), 0,062 - 1,000 (itraconazol) e 0,125 - 4,000 (cetoconazol). Detectaram-se 2 isolados resistentes ao itraconazol e 2 a anfotericina B (1 isolado de cada variedade por antif\u00fangico). Os dados mostram a import\u00e2ncia da determina\u00e7\u00e3o da variedade e da concentra\u00e7\u00e3o inibit\u00f3ria m\u00ednima de isolados de Cryptococcus neoformans para monitorar o desenvolvimento de resist\u00eancia e possibilitar uma terapia mais adequada na criptococose.<\/jats:p>","DOI":"10.1590\/s0037-86822008000200005","type":"journal-article","created":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T21:25:51Z","timestamp":1212701151000},"page":"158-162","source":"Crossref","is-referenced-by-count":10,"title":["Suscetibilidade a antif\u00fangicos de variedades de Cryptococcus neoformans isoladas de pacientes em hospital universit\u00e1rio"],"prefix":"10.1590","volume":"41","author":[{"given":"Paulo Roberto da","family":"Silva","sequence":"first","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosiley Aparecida de Souza","family":"Rabelo","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Sarreta","family":"Terra","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Nascimento Silva","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Tri\u00e2ngulo Mineiro"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"issue":"998","key":"ref1","article-title":"Images in clinical medicine: Cutaneous cryptococcosis","volume":"336","author":"Baker DJ","year":"1997","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/JCM.23.2.298-301.1986","article-title":"Results of survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin","volume":"23","author":"Calhoun DL","year":"1986","journal-title":"Bangladesh Journal of Clinical Microbiology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/313992","article-title":"Australasian Cryptococcal Study Group Epidemiology and Host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand","volume":"31","author":"Chen S","year":"2000","journal-title":"Clinical Infectious Diseases","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/JB.52.4.461-466.1946","article-title":"Urea decomposition as a means of differentiating Proteus and Paracolon cultures from each other and from salmonella and shigella types","volume":"52","author":"Christensen WB","year":"1946","journal-title":"Journal of Bacteriology","ISSN":"https:\/\/id.crossref.org\/issn\/0021-9193","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.33.3.535-540.1995","article-title":"Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing","volume":"33","author":"Colombo AL","year":"1995","journal-title":"Journal of Clinical Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0723-2020(00)80028-4","article-title":"Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans","volume":"23","author":"Diaz MR","year":"2000","journal-title":"Systematic and Applied Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0723-2020","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0140-6736(90)92283-N","article-title":"Ecology, life cycle, and infectious propagule of Cryptococcus neoformans","volume":"336","author":"Ellis DH","year":"1990","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1590\/S0074-02762003000600022","article-title":"In vitro susceptibility characteristics of Cryptococcus neoformans varieties from AIDS patients in Goiania","volume":"98","author":"Fernandes OFL","year":"2003","journal-title":"Mem\u00f3rias do Instituto Osvaldo Cruz"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/JCM.35.9.2243-2251.1997","article-title":"Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure","volume":"35","author":"Franzot SP","year":"1997","journal-title":"Journal of Clinical Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/IAI.31.2.560-563.1981","article-title":"Distribution of Cryptococcus neoformans in a natural site","volume":"31","author":"Fromtling RA","year":"1981","journal-title":"Infection and Immunity","ISSN":"https:\/\/id.crossref.org\/issn\/0019-9567","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/JCM.15.3.535-537.1982","article-title":"Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var gattii (serotypes B and C)","volume":"15","author":"Kwon-Chung KJ","year":"1982","journal-title":"Journal of Clinical Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref12","article-title":"Dados e Pesquisa em DST e Aids: Coordena\u00e7\u00e3o do programa nacional de DST\/Aids","year":"2002","journal-title":"Boletim Epidemiol\u00f3gico.AIDS"},{"key":"ref13","first-page":"515","article-title":"Cryptococcosis in the era of AIDS: 100 years after the discovery of Cryptococcus neoformans","volume":"8","author":"Mitchell TG","year":"1995","journal-title":"Clinical Microbiology and Infection","ISSN":"https:\/\/id.crossref.org\/issn\/1198-743X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1439-0507.2003.00872.x","article-title":"Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques","volume":"46","author":"Moraes EM","year":"2003","journal-title":"Mycoses","ISSN":"https:\/\/id.crossref.org\/issn\/0933-7407","issn-type":"print"},{"key":"ref15","first-page":"255","article-title":"Cryptococosis: clinical epidemiologycal laboratorial study and fungi varieties in 96 patients","volume":"39","author":"Moreira TA","year":"2006","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical","ISSN":"https:\/\/id.crossref.org\/issn\/0037-8682","issn-type":"print"},{"key":"ref16","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard M27-A2","year":"2002"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.42.2.471","article-title":"In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and resistant Cryptococcus neoformans isolates","volume":"42","author":"Nguyen MH","year":"1998","journal-title":"Antimicrobial Agents and Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/j.1875-9114.1998.tb03851.x","article-title":"The association between cryptococcal variety and immunocompetent and immunocompromised hosts","volume":"18","author":"Peachey PR","year":"1998","journal-title":"Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0277-0008","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762006000300002","article-title":"In vitro susceptibility to antifungal agents of environmental Cryptococcus spp. isolated in the city of Ribeir\u00e3o Preto, S\u00e3o Paulo, Brazil","volume":"101","author":"Pedroso RS","year":"2006","journal-title":"Mem\u00f3rias do Instituto Osvaldo Cruz"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jac\/dki393","article-title":"Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans","volume":"56","author":"Perkins A","year":"2005","journal-title":"Journal of Antimicrobial Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0305-7453","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1128\/JCM.43.8.3807-3810.2005","article-title":"In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole: global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods","volume":"43","author":"Pfaller MA","year":"2005","journal-title":"Journal of Clinical Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/AAC.40.9.1998","article-title":"Comparison of a Spectrophotometric Microdilution Method with RPMI-2% Glucose with the National Committee for Clinical Laboratory Standards Reference Macrodilution Method M27-P for in vitro Susceptibility Testing of Amphotericin B, Flucytosine, and Fluconazole against Candida albicans","volume":"40","author":"Rodriguez-Tudela JL","year":"1996","journal-title":"Antimicrobial Agents And Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0066-4804","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/jac\/dkh361","article-title":"Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002","volume":"54","author":"Sar B","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/0305-7453","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1590\/S0036-46652005000500003","article-title":"Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goi\u00e2nia City, Goi\u00e1s, Brazil","volume":"47","author":"Souza LKH","year":"2005","journal-title":"Revista do Instituto de Medicina Tropical de S\u00e3o Paulo","ISSN":"https:\/\/id.crossref.org\/issn\/0036-4665","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/clinids\/21.1.28","article-title":"Clinical and host differences between infections with the two varieties of Cryptococcus neoforman","volume":"21","author":"Speed B","year":"1995","journal-title":"Clinical Infectious Diseases","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref26","first-page":"167","article-title":"The brown colour effect (BCE) of Cryptococcus neoformans in the diagnosis, control and epidemiology of Cryptococcus neoformans infections in AIDS patients","volume":"266","author":"Staib F","year":"1987","journal-title":"Zentralbl fur Bakteriologie, Mikrobiologie, und Hygiene"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1128\/JCM.42.10.4815-4817.2004","article-title":"In vitro antifungal susceptibility of Cryptococcus gatti","volume":"42","author":"Trilles L","year":"2004","journal-title":"Journal of Clinical Microbiology","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsbmt\/v41n2\/a05v41n2.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T04:18:12Z","timestamp":1709007492000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822008000200005&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0037-86822008000200005"],"URL":"https:\/\/doi.org\/10.1590\/s0037-86822008000200005","relation":{},"ISSN":["0037-8682"],"issn-type":[{"value":"0037-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}